Burn weight loss patches: The best-selling weight loss supplements
LONDON — — The UK’s Health Protection Agency has warned of the risk of serious complications associated with the use of the popular weight loss pill Mylan’s “Burn” weight loss products.
Mylan is one of the biggest producers of the Burn product line, which includes patches for burns, bandages and other medical procedures.
Mylan has warned its Burn products are dangerous and pose a “risk of serious injury and death”.
The agency, which published its annual report on the use and risks of prescription medicines on Wednesday, said Burn products have been linked to:The products are sold by Mylan and its rival AstraZeneca and have been blamed for a rash of deaths.
The Health Protection Authority (HPA) said that the products can cause “serious and life-threatening injuries”.
The HPA also said that while “burn” is not considered a “medical emergency” by the NHS, it is the primary reason why patients should not receive “burn patch” treatment, as prescribed by the National Health Service.
“A patient with severe acute and/or subacute burn or burn injury will require an intensive hospital and long-term care rehabilitation programme to prevent further injury and potential death,” the HPA said.
“Burn patch” is a prescription drug which contains an ingredient called “methylene blue”, which can be toxic if inhaled, which is the reason the HPRA has warned that it is not recommended for use in patients with acute or subacutes burns or burn injuries.
The HPRE said “burn patches” could cause severe burns and that the product could be misused, resulting in death or serious injury.
The product’s label on the Mylan website says the patches are for people who have a “burn injury or injury to skin” and “are at high risk of skin damage”.
“A ‘burn patch’ contains a small amount of methylene blue, a substance that can be harmful if inhaling,” the Mylans website said.
“The product contains no warning label on its packaging that says ‘do not apply unless you have a burn injury’.”
A Mylan spokeswoman said: “Burn patches contain methylene Blue, which we do not recommend for use on patients with burns or burns injuries.
We do not currently recommend use of these patches on patients who are at high-risk of skin injury or burn.”
Mylan, which sells the Burn products under the Mylon brand, said it was working with the HPU to help people make an informed choice about their next steps.
The spokeswoman said it is “extremely important” that patients know about the “serious risks associated with use of Burn products”.
The Health Agency said that Mylan had failed to comply with the National Standards of Care for its products.
“These products are not covered by the NSC, nor are they approved by the regulator,” the agency said.
Mylans “Burn patch”, which was introduced in 2014, is a “patchwork of ingredients” that “may include a mixture of methylenetetrahydrofolate reductase, methylene-8,7-dichloroethanol and methylene green”.
The National Health Practitioners Regulation Authority has also issued a warning about the product’s safety, stating that its “possible use should be considered for the most severe burns, as well as for minor burns, if the patient has severe burn injuries and/ or burns that do not require intensive care”.
The regulator said that there are “reasonable grounds” for concern about the products safety, as they “could be potentially hazardous”.
“The NHPRA has identified the potential for the product to cause serious injury, death and/OR risk of long-lasting or permanent disability,” the regulator said.